Pub. Date : 2022 Apr
PMID : 35218109
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The PI3K/AKT signaling pathway suppressor, LY294002, was applied to treat the cells and the changes of KCNQ1OT1 expression and LOXL2, p-AKT, and AKT protein expressions were examined. | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | AKT serine/threonine kinase 1 | Homo sapiens |
| 2 | The PI3K/AKT signaling pathway suppressor, LY294002, was applied to treat the cells and the changes of KCNQ1OT1 expression and LOXL2, p-AKT, and AKT protein expressions were examined. | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | AKT serine/threonine kinase 1 | Homo sapiens |
| 3 | The PI3K/AKT signaling pathway suppressor, LY294002, was applied to treat the cells and the changes of KCNQ1OT1 expression and LOXL2, p-AKT, and AKT protein expressions were examined. | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | AKT serine/threonine kinase 1 | Homo sapiens |
| 4 | Additionally, LY294002 treatment caused low KCNQ1OT1 RNA expression and decreased LOXL2 and p-AKT protein expressions. | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | AKT serine/threonine kinase 1 | Homo sapiens |